Skip to main content

Health condition

Achondroplasia in adults

Achondroplasia, the most common form of disproportionate short stature, is caused by a specific FGFR3 variant - adult health centres on spinal stenosis surveillance, weight management, joint health and informed reproductive choices.

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against current NHS and UK specialist society guidance at the time of review.

  • 03

    Current for 2026

    Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.

Key facts

The essentials at a glance.

Which gene and test confirm it, who should be tested in the family, and which specialist to see.

  • Caused by a recurrent FGFR3 variant (G380R in most cases); autosomal dominant - about 80% arise as new mutations to average-height parents

  • The key adult complication is symptomatic spinal stenosis: leg pain, numbness or weakness on walking that eases on sitting deserves prompt assessment

  • Sleep apnoea, middle-ear disease and weight gain are common and treatable

  • Two parents with achondroplasia have a 25% chance per pregnancy of the severe homozygous form - reproductive counselling covers the options

Understanding the condition

What it is and what happens next.

What causes it, how it is confirmed, and the testing and specialist routes available in the UK.

What it is and how it presents

The FGFR3 variant behind achondroplasia acts like a brake permanently half-applied to cartilage growth, shaping the characteristic skeleton: average-sized trunk, shortened limbs, a relatively narrow spinal canal. That last feature defines adult life more than height does - the lumbar canal has less reserve, so disc and degenerative changes produce stenosis symptoms earlier and more often, and recognising the walking-triggered leg symptoms early keeps surgical options timely and effective.

Testing, surveillance and specialist care

Adults do best with access to a clinician who knows the condition - monitoring for stenosis, sleep studies where snoring or daytime fatigue appear, weight and joint strategies - and genetic counselling before pregnancy, where the genetics are precise enough to quantify every outcome. FGFR3-targeted drugs, developed in children, are an area to watch. NHS clinical genetics services carry some of the longest waits in the health service, often many months for a first appointment, whereas private genetic testing and a specialist review can typically be arranged within around two weeks.

Seeing a specialist

Who to see, and how quickly you can be seen.

The specialist for this condition is usually a clinical geneticist working with a skeletal dysplasia service. Your GP can refer you on the NHS, or you can arrange a private consultation directly.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any emergency symptoms.

Frequently asked

Common questions about Achondroplasia in adults.

Quick, plain-English answers to what people ask us most.

  • What is achondroplasia?

    Achondroplasia is the most common genetic form of dwarfism, caused by a mutation affecting bone growth, resulting in short stature with disproportionately short limbs relative to the torso.

  • What causes achondroplasia?

    It is caused by a mutation in the FGFR3 gene that disrupts normal cartilage-to-bone conversion during growth. Most cases arise as new mutations, though it can also be inherited from an affected parent.

  • What health issues do adults with achondroplasia face?

    Adults may experience spinal stenosis, back pain, joint problems from altered biomechanics, sleep apnoea, and a higher risk of certain complications like spinal cord compression that need ongoing monitoring.

  • Is achondroplasia dangerous?

    With good specialist care, most adults with achondroplasia live full, healthy lives, though spinal stenosis and related neurological complications require monitoring, as they can be serious if missed.

  • Is achondroplasia genetic?

    Yes, it is caused by a specific, well-understood genetic mutation and follows an autosomal dominant inheritance pattern, meaning an affected parent has a 50% chance of passing it to each child.

  • Can achondroplasia be treated?

    There is no cure, but management focuses on monitoring and treating complications such as spinal stenosis, sleep apnoea, and joint problems; growth-related treatments in childhood do not apply once skeletal maturity is reached in adulthood.

  • How is achondroplasia managed in adults?

    Management involves regular monitoring for spinal stenosis and joint issues, physiotherapy, pain management, weight management to reduce joint strain, and prompt referral for any new neurological symptoms.

  • How is spinal stenosis in achondroplasia treated if it develops?

    Mild symptoms may be managed with physiotherapy and pain control, but significant or progressive spinal stenosis usually requires surgical decompression to relieve pressure on the spinal cord or nerves.

  • Achondroplasia vs hypochondroplasia — what's the difference?

    Both are FGFR3-related skeletal conditions causing short stature, but hypochondroplasia is generally milder, with less pronounced disproportion and fewer complications, compared to the more significant limb shortening and higher complication rate seen in achondroplasia.

  • When should I see a doctor about achondroplasia-related symptoms, and how quickly can I be seen privately?

    See a doctor promptly for new back pain, numbness, weakness, or bladder/bowel changes, which could indicate spinal cord compression. NHS specialist referral can take many weeks, while private orthopaedic or neurosurgical assessment is often available within about two weeks.